Back to top
more

Better trading starts here.

Brokerage Reports

Research for ARAV

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

1 item in cart

View Cart/Checkout

ARAVIVE, INC [ARAV]

Reports for Purchase

Showing records 61 - 80 ( 104 total )

Company: ARAVIVE, INC

Industry: Medical - Generic Drugs

Record: 61

05/15/2020

Industry Report

Pages: 19

CORRECTED: ASCO Virtual Meeting Abstract Roundup

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 50.00

Research Provided by a Third Party

Company: ARAVIVE, INC

Industry: Medical - Generic Drugs

Record: 62

05/07/2020

Daily Note

Pages: 15

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 50.00

Research Provided by a Third Party

Company: ARAVIVE, INC

Industry: Medical - Generic Drugs

Record: 63

05/07/2020

Company Report

Pages: 5

Summer to Bring Ph 1b Update

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 10.00

Research Provided by a Third Party

Company: ARAVIVE, INC

Industry: Medical - Generic Drugs

Record: 64

05/04/2020

Industry Report

Pages: 25

COVID-19 Impact on Coverage Universe: Week of April 27 Update

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 75.00

Research Provided by a Third Party

Company: ARAVIVE, INC

Industry: Medical - Generic Drugs

Record: 65

04/30/2020

Daily Note

Pages: 4

Looking Toward the Future for New Assets; Important AVB-500 Update This Summer

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 10.00

Research Provided by a Third Party

Company: ARAVIVE, INC

Industry: Medical - Generic Drugs

Record: 66

04/27/2020

Daily Note

Pages: 26

COVID-19 Impact on Coverage Universe: Week of April 20 Update

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 75.00

Research Provided by a Third Party

Company: ARAVIVE, INC

Industry: Medical - Generic Drugs

Record: 67

04/20/2020

Daily Note

Pages: 21

COVID-19 Impact on Coverage Universe: Week of April 13 Update

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 75.00

Research Provided by a Third Party

Company: ARAVIVE, INC

Industry: Medical - Generic Drugs

Record: 68

04/13/2020

Company Report

Pages: 8

Management and Board Transition Strengthens Aravive''s Position; Important Upcoming Catalysts

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 25.00

Research Provided by a Third Party

Company: ARAVIVE, INC

Industry: Medical - Generic Drugs

Record: 69

04/09/2020

Daily Note

Pages: 4

Management, Board Changes

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 10.00

Research Provided by a Third Party

Company: ARAVIVE, INC

Industry: Medical - Generic Drugs

Record: 70

04/09/2020

Daily Note

Pages: 4

Management, Board Changes

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 10.00

Research Provided by a Third Party

Company: ARAVIVE, INC

Industry: Medical - Generic Drugs

Record: 71

04/06/2020

Industry Report

Pages: 15

COVID-19 Impact on Coverage Universe: Week of March 30 Update

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 50.00

Research Provided by a Third Party

Company: ARAVIVE, INC

Industry: Medical - Generic Drugs

Record: 72

04/06/2020

Daily Note

Pages: 15

COVID-19 Impact on Coverage Universe: Week of March 30 Update

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 50.00

Research Provided by a Third Party

Company: ARAVIVE, INC

Industry: Medical - Generic Drugs

Record: 73

03/30/2020

Company Report

Pages: 5

Aravive to Thrive in H2:20

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 10.00

Research Provided by a Third Party

Company: ARAVIVE, INC

Industry: Medical - Generic Drugs

Record: 74

03/30/2020

Daily Note

Pages: 12

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: ARAVIVE, INC

Industry: Medical - Generic Drugs

Record: 75

03/27/2020

Company Report

Pages: 6

2019 Results; COVID-19 May Impact

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 25.00

Research Provided by a Third Party

Company: ARAVIVE, INC

Industry: Medical - Generic Drugs

Record: 76

03/24/2020

Daily Note

Pages: 4

AVB-500 Begins IST in Urothelial Carcinoma; Key Catalysts In Ovarian Cancer Approach

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 10.00

Research Provided by a Third Party

Company: ARAVIVE, INC

Industry: Medical - Generic Drugs

Record: 77

02/21/2020

Daily Note

Pages: 6

Wheels Keep Turning on AXL

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: ARAVIVE, INC

Industry: Medical - Generic Drugs

Record: 78

02/21/2020

Daily Note

Pages: 12

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: ARAVIVE, INC

Industry: Medical - Generic Drugs

Record: 79

02/18/2020

Daily Note

Pages: 4

AVB-500 Moves Safely to Higher Doses

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 10.00

Research Provided by a Third Party

Company: ARAVIVE, INC

Industry: Medical - Generic Drugs

Record: 80

01/23/2020

Daily Note

Pages: 4

More Data to Arrive in 2020

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 10.00

Research Provided by a Third Party